Among the top five chain pharmacies in China, two are located in Hunan and three are mainly located in East China.

Yinxintang Pharmaceutical Group Co., Ltd. was established in June 2000 +0 1. Headquartered in Kunming, Yunnan Province, it is a leading retail pharmacy in Southwest China. The company has formed a pattern with Southwest as its core business area, South China as its strategic depth business area and North China as its supplementary business area. By the end of the third quarter of 20021,* * had 8,356 stores, including Yunnan Province.

In the first three quarters of 2002/kloc-0, Yinxintang achieved revenue of10.5 billion, a year-on-year increase of 13.6%, and net profit attributable to it was 764 million, a year-on-year increase of 26%.

Fourth place, Yifeng Pharmacy, main business areas: Central China and East China.

Yifeng Pharmacy Chain Co., Ltd. was established in June, 20001year, and its headquarters is located in Changsha, Hunan Province. Based on the Central South and East China markets, the company gradually expanded the national market. 20 18 successfully entered the North China market through the acquisition of Hebei Xinxing Pharmacy. By the end of the third quarter of 20021,the company had 7,246 stores (including 877 franchised stores), mainly distributed in

In the first three quarters of 2002/kloc-0, Yifeng Pharmacy realized revenue of109.4 billion, up by 16% year-on-year, and net profit attributable to it was 696 million, up by 2 1.5% year-on-year.

Third place, common people, main business area: Central China and East China.

Laobaixing Pharmacy Chain Co., Ltd. was established in 200 1, headquartered in Changsha, Hunan Province, and its stores are distributed in 22 provincial markets, among which there are many stores in Central China and East China, accounting for a relatively high proportion in Hunan, Shaanxi, Anhui, Guangxi and other provinces and cities. It is planned to acquire Huatuo Pharmacy in Hebei in the near future, and its market share in Hebei, Shaanxi and other places will be greatly improved after the acquisition. The company has always adhered to the development strategy of "direct operation, spark, joining and alliance", and its business scale has been expanding. By the end of the third quarter of 2002163, there were 8 stores, including 6055 direct stores and 2 franchisees.

In the first three quarters of 2002 1 128 billion, an increase of 1 1.5% year-on-year, and the net profit attributable to it was 533 million, an increase of 9.3% year-on-year.

Second place, Dashenlin: Main business area: South China.

Dashenlin Pharmaceutical Group Co., Ltd. was established in 1999, and its headquarters is located in Guangzhou, Guangdong Province. Its stores are located in ten provinces in China, including Guangdong, Guangxi, Henan and Hebei, among which the stores and revenues in South China account for more than 75%. By the end of the third quarter of 20021,the company * * * had 76 10 stores (joined).

In the first three quarters of 2002/kloc-0, the revenue of Da Shen Lin was123.6 billion, a year-on-year increase of 17.8%, and the net profit attributable to it was 8180,000 yuan, a year-on-year decrease of 5.6%.

First place, Guo Da Pharmacy, mainly engaged in North China and East China.

Guo Da Pharmacy is now a subsidiary of Sinopharm Consistency, a listed company of China Pharmaceutical Group, headquartered in Shanghai. 2065438+July 2008, it joined forces with the world pharmaceutical retail giant Wobolian to become the only Sino-foreign joint venture in the domestic pharmaceutical retail industry.

Guo Da Pharmacy is the largest chain pharmacy in China. In 2020, through the acquisition of Chengda Fiona Fang, Liaoning Province, we will expand the blank areas in Northeast China, consolidate the leading edge, form a pharmacy network covering coastal urban agglomerations in Northeast China, East China, North China and South China, and gradually spread to the northwest, Central China and inland urban agglomerations. By June 30th, 20021year, * * had 8,439 stores (5,890 direct stores, with 1549 franchisees), including 4,428 direct stores in North China, accounting for 64.3%, and10/4 in East China.

In the first half of 2002 108438+0 billion yuan, Guo Da Pharmacy realized its operating income and net profit of 263 million yuan.

(Because the third quarterly report of Sinopharm Consistency didn't mention the specific situation of big pharmacies in Guo Da, we can only use the data of the semi-annual report, but there should be no problem in ranking first in revenue).

At present, the market share of China pharmaceutical industry is still low, and several leading companies are mainly developing in one or two regions. The market share of the top ten pharmacies is only about 27%, and the market concentration needs to be improved. In the future, the speed of mergers and acquisitions in the pharmaceutical industry will still be relatively fast, and the market share of leading companies will be further improved.